Skip to main content
. 2022 Sep 21;13:977016. doi: 10.3389/fimmu.2022.977016

Figure 4.

Figure 4

Subgroup analysis for the relationship between TIGIT and progression-free survival (A) Grouped by different cancers (B) Grouped by location of TIGIT expression (C) Grouped by different cutoff values of TIGIT expression (D) Grouped by different postoperative treatments).